Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| CVS HEALTH Corp | 46,106 | reported | 03 Apr 2006 | tx 3+55,239 |
| PharMerica CORP | 0 | reported | 07 Dec 2017 | tx 73+2,959,821−2,874,917 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 07 Dec 2017 | SALE | PharMerica CORP | 519,589 | 29.25 USD | |
| 07 Dec 2017 | OTHER | PharMerica CORP | 440,001 | 29.25 USD | |
| 03 Nov 2017 | GIFT | PharMerica CORP | 51,282 | 0.00 USD | |
| 07 Dec 2017 | SALE | PharMerica CORP | 1,500 | 29.25 USD | |
| 07 Dec 2017 | GRANT_AWARD | PharMerica CORP | 146,521 | — | deriv |
| 07 Dec 2017 | OTHER | PharMerica CORP | 146,521 | — | deriv |
| 07 Dec 2017 | OTHER | PharMerica CORP | 182,801 | 18.41 USD | deriv |
| 24 Mar 2017 | GRANT_AWARD | PharMerica CORP | 50,080 | 0.00 USD | |
| 24 Mar 2017 | GRANT_AWARD | PharMerica CORP | 24,109 | 0.00 USD | |
| 24 Mar 2017 | TAX_WITHHOLDING | PharMerica CORP | 12,054 | 23.60 USD | |
| 17 Mar 2017 | TAX_WITHHOLDING | PharMerica CORP | 9,640 | 22.50 USD | |
| 20 Mar 2017 | TAX_WITHHOLDING | PharMerica CORP | 6,433 | 23.15 USD | |
| 15 Mar 2017 | EXERCISE | PharMerica CORP | 155,836 | 18.48 USD | |
| 15 Mar 2017 | EXERCISE | PharMerica CORP | 155,836 | 0.00 USD | deriv |
| 13 Mar 2017 | TAX_WITHHOLDING | PharMerica CORP | 5,987 | 23.00 USD | |
| 17 Mar 2016 | GRANT_AWARD | PharMerica CORP | 64,528 | 0.00 USD | |
| 17 Mar 2016 | GRANT_AWARD | PharMerica CORP | 57,841 | 0.00 USD | |
| 04 Mar 2016 | TAX_WITHHOLDING | PharMerica CORP | 11,152 | 23.48 USD | |
| 10 Feb 2016 | TAX_WITHHOLDING | PharMerica CORP | 123,090 | 27.75 USD | |
| 10 Feb 2016 | EXERCISE | PharMerica CORP | 166,664 | 14.89 USD | |
| 10 Feb 2016 | EXERCISE | PharMerica CORP | 166,664 | 0.00 USD | deriv |
| 03 Jun 2015 | SALE | PharMerica CORP | 7,000 | 32.62 USD | |
| 03 Jun 2015 | SALE | PharMerica CORP | 79,344 | 32.50 USD | |
| 03 Jun 2015 | SALE | PharMerica CORP | 2,145 | 32.75 USD | |
| 02 Jun 2015 | SALE | PharMerica CORP | 15,661 | 33.29 USD |
2 purchases reported after at least 12 months of silence — most recent on 29 Feb 2012.